Recent publications
-
Advocates Demand Migrants’ Inclusion in EU and UK COVID-19 Vaccine Plans
Global advocates sent open letters to the UK and EU heads of state, and European Commission leadership urging for immediate provision of COVID-19 vaccines to all people who are migrants, refugees, displaced or non-national people residing in the UK and EU. More
-
Harnessing the COVID-19 Response Towards Hepatitis C Elimination
On February 3, 2021, Treatment Action Group, Médecins du Monde, hepCoalition, and the UNITE network convened a virtual policy dialogue among parliamentarians, global civil society organizations, and community leaders to share how COVID-19 has impacted global hepatitis C virus elimination efforts. The virtual policy dialogue offered an opportunity to reflect on the latest scientific progress and policy innovations from the International AIDS Society COVID-19 Prevention Conference. More
-
African Declaration to Eliminate Hepatitis C and Improve the Health of People Who Use Drugs Cape Town, South Africa, 20 February 2020
We, the community of people working to eliminate hepatitis C in the African region express alarm regarding the increasing impact of drug use, hepatitis C, and other viral co-infections (including HIV and hepatitis B) on the health and well-being of people who use drugs and the limited access to evidence-based services effective for the prevention, diagnosis and treatment of hepatitis C infection and for improving the health of people who use drugs. More
-
Access to Hepatitis C Treatment and Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected Issue brief
Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans. An issue brief, developed by Treatment Action Group (TAG) and Médecins du Monde (MdM) based on crowdsourced hepatitis C data, aims to provide supplemental evidence for advocates on hepatitis C treatment uptake and care among people who inject drugs, which could help inform national and regional campaigns. More
-
Who Has Access to Hepatitis C Testing? Liberate Our Diagnostics! Issue brief
Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up testing services and linking people to treatment and care, as part of implementing their national hepatitis plans. An issue brief, developed by Treatment Action Group (TAG) and Médecins du Monde (MdM) based on crowdsourced hepatitis C data, aims to provide supplemental evidence for advocates on hepatitis C diagnostics availability and pricing, which could help inform national and regional campaigns. More